Evidence map›Paper›PMID 40472191›Full record

ArticleeLife2025

Chalkophore-mediated respiratory oxidase flexibility controls

John A Buglino, Yaprak Ozakman, Chad E Hatch, Anna Benjamin, Derek S Tan, Michael S Glickman

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Effect of Ammonia onAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. CrpH ofFrontiers in microbiology · 2026
    Article
  4. Article
  5. Article
  6. Copper-chelating natural products.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

John A Buglino *Immunology Program, Sloan Kettering Institute, New York, United States.ORCID https://orcid.org/0000-0001-8961-8672
Yaprak Ozakman *Immunology Program, Sloan Kettering Institute, New York, United States.ORCID https://orcid.org/0000-0003-3777-0546
Chad E HatchChemical Biology Program, Sloan Kettering Institute, New York, United States.ORCID https://orcid.org/0000-0001-6808-5117
Anna BenjaminImmunology Program, Sloan Kettering Institute, New York, United States.ORCID https://orcid.org/0000-0001-6159-6440
Derek S TanChemical Biology Program, Sloan Kettering Institute, New York, United States.ORCID https://orcid.org/0000-0002-7956-9659
Michael S GlickmanImmunology Program, Sloan Kettering Institute, New York, United States.ORCID https://orcid.org/0000-0001-7918-5164

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosisR01AI138446 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI GLICKMAN, MICHAEL S · 2019 to 2023
$2.3M
National Institute of Allergy and Infectious Diseases R01AI138446NCI NIH HHS P30 CA008748NIAID NIH HHS R01 AI138446
6 · The paper itself

Abstract

Oxidative phosphorylation has emerged as a critical therapeutic vulnerability of

Indexed as

Electron Transport Complex IVMycobacterium tuberculosisOxidoreductasesAnimalsCopperFemaleHost-Pathogen InteractionsMiceMice, Inbred C57BLTuberculosisVirulenceCopperElectron Transport Complex IVOxidoreductasesCopperinfectious diseasemicrobiologyM. tuberculosisnutrional immunityoxidative phosphorylationtuberculosis

Identifiers

PMID40472191
PMCPMC12140626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.